ATGC awarded NIH fast track STTR grant to develop novel nanoparticle delivery system for CRISPR/Cas9
Programmable nuclease technologies, especially CRISPR/Cas9 have revolutionized the field of gene editing, and have been credited with the potential to ... Read More